Heliyon (May 2024)

The critical impacts of cytokine storms in respiratory disorders

  • Shahana Riyaz Tramboo,
  • Ahmed M.E. Elkhalifa,
  • Syed Quibtiya,
  • Sofi Imtiyaz Ali,
  • Naveed Nazir Shah,
  • Syed Taifa,
  • Rabia Rakhshan,
  • Iqra Hussain Shah,
  • Muzafar Ahmad Mir,
  • Masood Malik,
  • Zahid Ramzan,
  • Nusrat Bashir,
  • Shubeena Ahad,
  • Ibraq Khursheed,
  • Elsharif A. Bazie,
  • Elsadig Mohamed Ahmed,
  • Abozer Y. Elderdery,
  • Fawaz O. Alenazy,
  • Awadh Alanazi,
  • Badr Alzahrani,
  • Muharib Alruwaili,
  • Emad Manni,
  • Sanaa E. Hussein,
  • Ezeldine K. Abdalhabib,
  • Showkat Ul Nabi

Journal volume & issue
Vol. 10, no. 9
p. e29769

Abstract

Read online

Cytokine storm (CS) refers to the spontaneous dysregulated and hyper-activated inflammatory reaction occurring in various clinical conditions, ranging from microbial infection to end-stage organ failure. Recently the novel coronavirus involved in COVID-19 (Coronavirus disease-19) caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) has been associated with the pathological phenomenon of CS in critically ill patients. Furthermore, critically ill patients suffering from CS are likely to have a grave prognosis and a higher case fatality rate. Pathologically CS is manifested as hyper-immune activation and is clinically manifested as multiple organ failure. An in-depth understanding of the etiology of CS will enable the discovery of not just disease risk factors of CS but also therapeutic approaches to modulate the immune response and improve outcomes in patients with respiratory diseases having CS in the pathogenic pathway. Owing to the grave consequences of CS in various diseases, this phenomenon has attracted the attention of researchers and clinicians throughout the globe. So in the present manuscript, we have attempted to discuss CS and its ramifications in COVID-19 and other respiratory diseases, as well as prospective treatment approaches and biomarkers of the cytokine storm. Furthermore, we have attempted to provide in-depth insight into CS from both a prophylactic and therapeutic point of view. In addition, we have included recent findings of CS in respiratory diseases reported from different parts of the world, which are based on expert opinion, clinical case-control research, experimental research, and a case-controlled cohort approach.

Keywords